Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of $395.06 million as of November 6, 2025. Its market cap has increased by 141.62% in one year.

• Market Cap: 395.06M
• Enterprise Value: 353.78M
• 1-Year Change: 141.62%
• Ranking: #3207
• Category: Small-Cap
• Stock Price: $1.73

Market Cap Chart

Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $395.06M, an increase of 168.02%. That is a compound annual growth rate of 3.73%.

Market Cap History

Date	Market Cap	% Change
Nov 5, 2025	415.60M	338.40%
Dec 31, 2024	94.80M	-50.29%
Dec 29, 2023	190.70M	-4.12%
Dec 30, 2022	198.90M	-51.84%
Dec 31, 2021	413.00M	56.44%
Dec 31, 2020	264.00M	98.05%
Dec 31, 2019	133.30M	15.01%
Dec 31, 2018	115.90M	-57.51%
Dec 29, 2017	272.80M	-26.90%
Dec 30, 2016	373.20M	-4.09%
Dec 31, 2015	389.10M	25.52%
Dec 31, 2014	310.00M	28.15%
Dec 31, 2013	241.90M	51.38%
Dec 31, 2012	159.80M	-45.26%
Dec 30, 2011	291.90M	-26.38%
Dec 31, 2010	396.50M	181.41%
Dec 31, 2009	140.90M	234.68%
Dec 31, 2008	42.10M	347.87%
Dec 31, 2007	9.40M	54.10%
Dec 29, 2006	6.10M	10.91%
Dec 30, 2005	5.50M	-79.55%
Dec 31, 2004	26.90M	43.09%
Dec 31, 2003	18.80M	-10.05%
Dec 31, 2002	20.90M	-60.79%
Dec 31, 2001	53.30M	-37.37%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	838.98B
Johnson & Johnson	450.35B
AbbVie	387.23B
UnitedHealth Group	291.36B
AstraZeneca	251.76B
Novartis AG	242.27B
Abbott Laboratories	217.24B
Thermo Fisher Scientific	212.97B